Polydopamine Surface Engineering of Iron Single-Atom Nanozyme: a Novel Strategy for Doxorubicin Immobilization, Tumor Microenvironment Remodeling and Synergistic Multimodel Therapy

Author:

Liu Meiling1,Liu Jing1,Wang Minjuan2,Chen Haoyu1,Yang Xing1,Wei Mingjie2,Wang Xingfeng3,Shan Shigang3,Zhu Xiaohua1,Zhang Youyu1,Yao Shouzhuo1

Affiliation:

1. Hunan Normal University

2. School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology

3. Hubei University of Science and Technology

Abstract

Abstract

The variation in tumor microenvironment, specifically the levels of cellular H2O2/O2/GSH, plays a crucial role in the effectiveness of cancer therapy in nanozyme-drug systems. In this study, bioinspired polydopamine was utilized to surface engineer the rhombic dodecahedron morphology iron-based SANzyme (Fe SANzyme), which exhibited multiple mimetic activities including oxidase (OXD)-like, peroxidase (POD)-like, catalase (CAT)-like, and glutathione peroxidase (GPx)-like activities. The Fe SAN-PDA was intricately designed as a nanoplatform for drug immobilization, remodeling the tumor microenvironment (TME) and enabling synergistic multimodal tumor therapy. The presence of abundant quinone structures on PDA surface facilitated the creation of a conductive microenvironment for the immobilization of doxorubicin (DOX) through Michael addition/Schiff base reaction. The Fe SAN-PDA@DOX can catalyze high level of H2O2 in TME to produce oxygen and alleviate hypoxia, convert the produced oxygen to the toxic ·OH, and deplete intracellular glutathione. Coating with hyaluronic acid (HA) enhanced the biocompatibility and targeting ability of the composite. The exceptional photothermal performance of Fe SAN-PDA@DOX@HA, combined with the nanozyme catalysis, resulted in sustained chemodynamic/photothermal/ chemotherapy is achieved in a mouse mammary carcinoma model. This research highlights the synergistic therapeutic effects resulting from the combination of the multi-enzymatic activities of Fe SAN with multifunctional PDA, offering a novel a novel strategy for doxorubicin immobilization, tumor microenvironment remodeling and synergistic multimodal therapy.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3